These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26153256)

  • 1. Evaluating left ventricular systolic dysfunction: Stress echocardiography.
    Argulian E; Chaudhry FA
    J Nucl Cardiol; 2015 Oct; 22(5):957-60. PubMed ID: 26153256
    [No Abstract]   [Full Text] [Related]  

  • 2. Debates: Introduction.
    Iskandrian AE
    J Nucl Cardiol; 2015 Oct; 22(5):952. PubMed ID: 26153259
    [No Abstract]   [Full Text] [Related]  

  • 3. How to differentiate the etiology of LV dysfunction as to whether it is "ischemic cardiomyopathy" or "dilated non-ischemic cardiomyopathy"? Invasive coronary and myocardial assessment is the approach of first choice.
    Ahn SG; Samady H
    J Nucl Cardiol; 2015 Oct; 22(5):953-6. PubMed ID: 26153258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Imaging techniques in heart failure].
    Martínez Dolz L; Almenar Bonet L
    Rev Esp Cardiol; 2006 Jul; 6 Suppl F():27-45. PubMed ID: 17144975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine Tc-99m tetrofosmin SPECT in differentiation of ischemic from nonischemic cardiomyopathy in patients with LV systolic dysfunction.
    Her SH; Yoon HJ; Lee JM; Jin SW; Youn HJ; Seung KB; Kim JH
    Clin Nucl Med; 2008 Jul; 33(7):459-63. PubMed ID: 18580229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of dobutamine stress echocardiography in myocardial viability.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mystery of myocardial midwall late enhancement?
    Alter P
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1569-70. PubMed ID: 25117644
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical case of the month. Left ventricular apical ballooning (Tako-Tsubo cardiomyopathy)].
    Marchal V; Allaf DE
    Rev Med Liege; 2007 Feb; 62(2):71-2. PubMed ID: 17461293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia.
    Farzaneh-Far A; Ariyarajah V; Shenoy C; Dorval JF; Kaminski M; Curillova Z; Wu H; Brown KB; Kwong RY
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):378-88. PubMed ID: 21492813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of ischemic from nonischemic cardiomyopathy during dobutamine stress by left ventricular long-axis function: additional effect of left bundle-branch block.
    Duncan AM; Francis DP; Gibson DG; Henein MY
    Circulation; 2003 Sep; 108(10):1214-20. PubMed ID: 12939221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exertion-induced myocardial ischemia has little influence on ventricular remodeling in post-infarction patients with preserved systolic function].
    Temporelli PL; Corrå U; Marcassa C; Galli M; Imparato A; Giannuzzi P
    G Ital Cardiol; 1996 Jul; 26(7):729-37. PubMed ID: 8964315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction.
    Schinkel AF; Bax JJ; Delgado V; Poldermans D; Rahimtoola SH
    Am J Med; 2010 Nov; 123(11):978-86. PubMed ID: 21035587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction.
    Rambaldi R; Bax JJ; Rizzello V; Biagini E; Valkema R; Roelandt JR; Poldermans D
    Coron Artery Dis; 2005 May; 16(3):141-5. PubMed ID: 15818082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of contrast in stress echocardiography].
    Brochet E
    Arch Mal Coeur Vaiss; 2004 Jan; 97(1):46-52. PubMed ID: 15002711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nonischemic cardiomyopathies using cardiovascular magnetic resonance.
    O'Hanlon R; Prasad SK; Pennell DJ
    J Nucl Cardiol; 2008; 15(3):400-16. PubMed ID: 18513647
    [No Abstract]   [Full Text] [Related]  

  • 16. Ischaemic vs non-ischaemic dilated cardiomyopathy: The value of nuclear cardiology techniques.
    Caobelli F; Bengel FM
    J Nucl Cardiol; 2015 Oct; 22(5):971-4. PubMed ID: 26153257
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk stratification after acute myocardial infarction].
    Candell Riera J
    Rev Esp Cardiol; 2003 Mar; 56(3):303-13. PubMed ID: 12622960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nuclear cardiology in the diagnosis and risk stratification of women with ischemic heart disease.
    Esteves FP; Travin MI
    Semin Nucl Med; 2014; 44(6):423-38. PubMed ID: 25362233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus.
    Somaratne JB; Whalley GA; Bagg W; Doughty RN
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):109-25. PubMed ID: 18095911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear cardiology and heart failure.
    Giubbini R; Milan E; Bertagna F; Mut F; Metra M; Rodella C; Dondi M
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):2068-80. PubMed ID: 19672592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.